EYE nova eye medical limited

Ann: ELX LEAD Clinical trial results, page-5

  1. 7,579 Posts.
    lightbulb Created with Sketch. 1187
    77% reduction in rate of progression - what is the 'average' time for progression from intermediate to late stage ? i.e. what is the 'average' time delay from intermediate to late stage for the 'average' patient receiving 2RT treatments ? & I guess also how many treatments at what cost ?

    Lots of details to come out but their will be plenty of people willing to play the % game & try to delay AMD onset with 2RT treatments.

    Pay per treatment. I was hoping this would be a revenue model as just selling the 2RT lasers would be a poor outcome.

    elx.JPG
    .
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
14.0¢
Change
-0.005(3.45%)
Mkt cap ! $39.85M
Open High Low Value Volume
14.5¢ 15.0¢ 14.0¢ $34.30K 241.0K

Buyers (Bids)

No. Vol. Price($)
10 169738 14.0¢
 

Sellers (Offers)

Price($) Vol. No.
14.5¢ 10000 1
View Market Depth
Last trade - 16.10pm 07/08/2025 (20 minute delay) ?
EYE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.